UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000027963
Receipt number R000032034
Scientific Title Pilot study for a randomized controlled trial of preventing locomotive syndrome through exercise at local pharmacies
Date of disclosure of the study information 2017/06/28
Last modified on 2021/01/04 14:45:24

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Pilot study for a randomized controlled trial of preventing locomotive syndrome through exercise at local pharmacies

Acronym

Pilot study for preventing locomotive syndrome through exercise at local pharmacies

Scientific Title

Pilot study for a randomized controlled trial of preventing locomotive syndrome through exercise at local pharmacies

Scientific Title:Acronym

Pilot study for preventing locomotive syndrome through exercise at local pharmacies

Region

Japan


Condition

Condition

Locomotive syndrome

Classification by specialty

Orthopedics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To conduct a pilot study for a randomized controlled trial to examine the feasibility and the efficacy of the exercises for preventing locomotive syndrome at local pharmacies.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Locomotive syndrome risk test: the two-step test

Key secondary outcomes

Locomotive syndrome risk test: the stand-up test, 25-question risk assessment
One-leg standing time with eyes open
Leg strength evaluation
SF-8
Number of times the participant comes to the pharmacy during the research period
The pharmacist's advices given at the pharmacy regarding the participant's health conditions
Information of the participant's health conditions obtained by the pharmacist during the research period
Number of participants who could not come to the pharmacy on the scheduled date
The exercise rate


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Behavior,custom

Interventions/Control_1

The exercise lesson
Pharmacists check that the participants do the exercises correctly once a month at the pharmacy

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

65 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Person who meets all the following criteria:
Age 65 or older at the time of consent
Person who is unable to stand up from a height of 40 cm on one leg, either your right leg or left leg
Person who gives his/her consent in writing to participate in the study

Key exclusion criteria

Person whose doctor orders not to do exercise
Person with the certification of needed long-term care
Person who has received a diagnosis of mental disorders
Person who goes to sports facilities and receives exercise guidance on a regular basis
Person whose locomotive syndrome risk is level 2
Person who does not come to the pharmacy after the observation period
Person with joint range of motion limitation
Person with pain, swelling, inflammation, injury, paralysis, or skin lesion of the lower limbs
Person who is allergic to the materials of leg-strength evaluation tools

Target sample size

12


Research contact person

Name of lead principal investigator

1st name Chigusa
Middle name
Last name Kikuchi

Organization

Nagoya City University Graduate School of Pharmaceutical Sciences

Division name

Department of Clinical Pharmacy

Zip code

467-8603

Address

3-1 Tanabe-dori, Mizuho-ku, Nagoya, Japan

TEL

+81-52-836-3460

Email

kikuchi@phar.nagoya-cu.ac.jp


Public contact

Name of contact person

1st name Chigusa
Middle name
Last name Kikuchi

Organization

Nagoya City University Graduate School of Pharmaceutical Sciences

Division name

Department of Clinical Pharmacy

Zip code

467-8603

Address

3-1 Tanabe-dori, Mizuho-ku, Nagoya, Japan

TEL

+81-52-836-3460

Homepage URL


Email

kikuchi@phar.nagoya-cu.ac.jp


Sponsor or person

Institute

Nagoya City University Graduate School of Pharmaceutical Sciences

Institute

Department

Personal name



Funding Source

Organization

OTC Self-Medication Promotion Foundation

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nagoya City University Hospital Clinical Research Review board

Address

1 Kawasumi, Mizuho-ku, Nagoya 467-8603, Japan

Tel

+81-52-853-8321

Email

clinical_research@med.nagoya-cu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 06 Month 28 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2017 Year 05 Month 23 Day

Date of IRB


Anticipated trial start date

2017 Year 06 Month 28 Day

Last follow-up date

2018 Year 03 Month 26 Day

Date of closure to data entry

2018 Year 08 Month 31 Day

Date trial data considered complete

2018 Year 08 Month 31 Day

Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 06 Month 28 Day

Last modified on

2021 Year 01 Month 04 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000032034


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name